Cencora — Aug 5, 2026 release
Fiscal 2026 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001140859-26-000032
Showing in the filing
Quarterly cash dividend
“$0.60 per common share”
Period
FY2026
Measure
Declared action
Source
Prose
All guidance in this release · 17
Revenue for FY2026
“4% to 6% growth”
U.S. Healthcare Solutions Segment Revenue for FY2026
“4% to 6% growth”
International Healthcare Solutions Segment R… for FY2026
“~8% growth”
Other Revenue for FY2026
“~6% growth”
Other (2) for FY2026
“~6% growth”
Adjusted operating income for FY2026
“13% to 14% growth”
U.S. Healthcare Solutions Segment (2) - Adju… for FY2026
“14.5% to 15.5% growth”
International Healthcare Solutions Segment (… for FY2026
“~9% growth”
Other (2) - Adjusted operating income for FY2026
“~10% growth”
Adjusted diluted earnings per share for FY2026
“$17.75 to $17.95”
Adjusted Diluted EPS for FY2026
“$17.75 to $17.95”
Net interest expense for FY2026
“~$490M”
Adjusted effective tax rate for FY2026
“~20%”
Diluted weighted average shares outstanding for FY2026
“~194M”
Adjusted free cash flow for FY2026
“~$3.0B”
Capital expenditures for FY2026
“~$900M”
Quarterly cash dividend for FY2026
“$0.60 per common share”
Exhibit 99.1 · the passage around this item
… earlier in the release
For additional details regarding updated guidance expectations on a constant currency basis, please refer to our slide presentation for investors posted on the Company’s website at investor.cencora.com. Dividend Declaration The Company’s Board of Directors declared a quarterly cash dividend of $0.60 per common share, payable August 31, 2026, to stockholders of record at the close of business on August 14, 2026. Conference Call & Slide Presentation The Company will host a conference call to discuss its operating results at 8:30 a.m. ET on August 5, 2026. A slide presentation for investors has also been posted on the Company’s website at investor.cencora.com. Participating in the conference call will be: • Robert P. Mauch, President & Chief Executive Officer • Eva C. Boratto, Executive Vice President & Chief Financial Officer The dial-in number for the live call will be +1 (833) 461-5787. From outside the United States and Canada, dial +1 (585) 542-9983. The meeting ID for the call will be 632 369 927. The live call will also be webcast via the Company’s website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call. A replay of the webcast will be posted on investor.cencora.com approximately one hour after the completion of the call and will remain available for one year. Upcoming Investor Event Cencora management will be attending the following investor event in the coming months: • Wells Fargo Hea
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.